ÂÜÀòÂÒÂ×

Rodolphe Barrangou is a distinguished academic and industry leader currently serving on the Board of Directors for Ki Tua Fund and as the T. R. Klaenhammer Distinguished Professor at North Carolina State University since February 2013. Barrangou has held the position of Editor In Chief for The CRISPR Journal since November 2017 and is a co-founder and Chief Scientific Officer at Ancilia Biosciences since December 2019. Additional advisory roles include the Scientific Advisory Board for Invaio Sciences and Inari. Barrangou has a robust entrepreneurial background with co-founding positions at Intellia Therapeutics, Inc. and Locus Biosciences, Inc. Barrangou has also contributed to the academic field at Penn State University as an Adjunct Professor from 2010 to 2016. Educational credentials include an MBA from the Wisconsin School of Business and multiple degrees from North Carolina State University and Université de Technologie de Compiègne.